Strategic CRM implementation elevates client service delivery across complex project lifecycles We can now easily track ...
Antengene, UCB sign global exclusive license agreement to develop, manufacture and commercialize ATG-201: Hong Kong Friday, March 6, 2026, 14:00 Hrs [IST] Antengene Corporation Li ...
UCB obtains worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseasesDeal ...
Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific ...
FleetDomain’s Fleet Management Information System addresses the challenges and risks associated with fleet management on one ...
Inflight connectivity is evolving from a luxury to a fundamental passenger expectation, transforming the aircraft into a ...
Belgium’s largest drugmaker UCB and Hong Kong based biotech Antengene have entered into an agreement that grants UCB a ...
Many private security companies have been using smartphones and apps as simple as WhatsApp to scan vehicle discs and licence ...
Ben is the founder of Athletic Truth Group (ATG), an online and brick-and-mortar training system rooted in rehabilitative ...
Philharmonia Baroque Orchestra & Chorale has announced its lineup for The Power of Music—its first season curated by newly ...
Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aims to harness, direct and optimize their immune suppressive properties to address serious ...
Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...